Follow the 서린바이오 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 서린바이오 has recorded 25 insider filings. Market capitalisation: €45.2bn. The latest transaction was filed on 2 April 2026 (Purchase). Among the most active insiders: 황을문. The full history is openly available.
25
Insider Decl.
0
Thresholds
·
12 ops.
Buy Volume
·
0 ops.
Sell Volume
24Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,092 of 26,213 companies
39.1
score / 100
Value
50
Quality
28
FCF yld11%
Earn yld1.8%
EV/EBITDA19.1x
ROE0.5%
Gross mgn22%
Net mgn0.9%
Debt/EBITDA4.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.